False Claims Act

Massachusetts-based medical device manufacturer Alere (acquired by Abbott Laboratories in 2017) and its subsidiary Alere San Diego…

On July 26, 2017, the Washington State Attorney General (“AG”) Bob Ferguson (“Ferguson”) announced one of the State’s largest…

In a nearly decade long lawsuit involving the dialysis company Fresenius, and allegations that the company violated the False…

Several significant False Claims Act settlements and judgments in the first six months of 2017 suggest this year will result in…

The United States Food and Drug Administration (FDA) Office of Prescription Drug Promotion (OPDP) sent a warning letter to Cipher…

In late August 2017, the United States Department of Justice (DOJ) announced a $12 million settlement with Sightpath Medical and…

In a much-anticipated U.S. Court of Appeals decision, the Fourth Circuit on February 14, 2017, in evaluating the issue of whether…

Pharmaceutical and medical device manufacturers continue to face intense scrutiny from regulatory and enforcement agencies, as…

On Monday, May 1, 2017, the United States Court of Appeals for the Third Circuit stopped a False Claims Act suit that accused…

While False Claims Act cases are relatively common in the life science industry, FCA cases for cGMP violations are not. This…